These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19297635)

  • 41. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of sex offenders].
    Hiob J
    Ther Ggw; 1977 Apr; 116(4):593-626. PubMed ID: 877915
    [No Abstract]   [Full Text] [Related]  

  • 43. Osteoporosis and androgen-depleting drugs in sex offenders.
    Gooren LJ; Lips P; Gijs L
    Lancet; 2001 Apr; 357(9263):1208-9. PubMed ID: 11332437
    [No Abstract]   [Full Text] [Related]  

  • 44. Chemical castration: MPA treatment of the sexual offender.
    Fitzgerald EA
    Am J Crim Law; 1990; 18(1):1-60. PubMed ID: 15991431
    [No Abstract]   [Full Text] [Related]  

  • 45. Sexually aggressive men.
    Bradford JM; Bourget D
    Psychiatr J Univ Ott; 1987 Sep; 12(3):169-75. PubMed ID: 3313481
    [No Abstract]   [Full Text] [Related]  

  • 46. Assessing sexual deviance: a comparison of physiological, historical, and self-report measures.
    Stinson JD; Becker JV
    J Psychiatr Pract; 2008 Nov; 14(6):379-88. PubMed ID: 19057239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Agency, relatedness, inner peace, and problem solving in sexual offending: how sexual offenders prioritize and operationalize their good lives conceptions.
    Barnett G; Wood JL
    Sex Abuse; 2008 Dec; 20(4):444-65. PubMed ID: 18948428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Ward and Hudson pathways model of the sexual offense process applied to offenders with intellectual disability.
    Lindsay WR; Steptoe L; Beech AT
    Sex Abuse; 2008 Dec; 20(4):379-92. PubMed ID: 18941166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE.
    Abouassaly R; Paciorek A; Ryan CJ; Carroll PR; Klein EA
    Cancer; 2009 Oct; 115(19):4470-6. PubMed ID: 19637339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Psychological stress as an indication criterion. Remarks on "medicamentous castration"].
    Horn HJ
    Nervenarzt; 1971 Jun; 42(6):312-6. PubMed ID: 5581170
    [No Abstract]   [Full Text] [Related]  

  • 51. Manipulation of sexual behaviour by anti-androgens.
    van Werff ten Bosch JJ
    Psychiatr Neurol Neurochir; 1973; 76(2):147-9. PubMed ID: 4700932
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapy of sex-drive abnormalities in medical practice].
    Tessmann R
    Med Welt; 1972 Feb; 23(6):188-91. PubMed ID: 5062181
    [No Abstract]   [Full Text] [Related]  

  • 53. [Sex deviations and their chemical treatment].
    Delaloye R
    Rev Med Suisse Romande; 1974 Jul; 94(7):565-73. PubMed ID: 4842197
    [No Abstract]   [Full Text] [Related]  

  • 54. Finding a place for sex offenders.
    Enos GA
    Behav Healthc; 2006 Sep; 26(9):17-21. PubMed ID: 17086835
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lifers on the outside: sex offenders and disintegrative shaming.
    Robbers ML
    Int J Offender Ther Comp Criminol; 2009 Feb; 53(1):5-28. PubMed ID: 18268079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The therapeutic use of androgen-depleting hormone.
    Money J
    Int Psychiatry Clin; 1971; 8(4):165-74. PubMed ID: 5155162
    [No Abstract]   [Full Text] [Related]  

  • 58. The diagnostic reliability of sexual sadism.
    Doren D; Elwood R
    Sex Abuse; 2009 Sep; 21(3):251-61. PubMed ID: 19605692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular disease with androgen deprivation: the (forgotten) role of testosterone.
    Aragon-Ching JB
    J Clin Oncol; 2009 Dec; 27(35):e261; author reply e262. PubMed ID: 19884519
    [No Abstract]   [Full Text] [Related]  

  • 60. Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience.
    DiBlasio CJ; Malcolm JB; Hammett J; Wan JY; Aleman MA; Patterson AL; Wake RW; Derweesh IH
    BJU Int; 2009 Nov; 104(9):1208-14. PubMed ID: 19388987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.